Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Design, synthesis, biological activity evaluation and structure-activity relationships of new steroidal aromatase inhibitors. The case of C-ring and 713 substituted steroids
Publication

Publications

Design, synthesis, biological activity evaluation and structure-activity relationships of new steroidal aromatase inhibitors. The case of C-ring and 713 substituted steroids

Title
Design, synthesis, biological activity evaluation and structure-activity relationships of new steroidal aromatase inhibitors. The case of C-ring and 713 substituted steroids
Type
Article in International Scientific Journal
Year
2023
Authors
Roleira, FMF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, SC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gomes, AR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Varela, CL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Amaral, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Augusto, TV
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Georgina Correia da Silva
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Romeo, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alcaro, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Teixeira, N
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tavares-da-Silva, EJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Bioorganic ChemistryImported from Authenticus Search for Journal Publications
Vol. 131
ISSN: 0045-2068
Publisher: Elsevier
Indexing
Other information
Authenticus ID: P-00X-PNG
Abstract (EN): In this work, new steroidal aromatase inhibitors (AIs) were designed, synthesized, and tested. In one approach, C -ring substituted steroids namely those functionalized at C-11 position with an alpha or 13 hydroxyl group or with a carbonyl group as well as C-9/C-11 steroidal olefins and epoxides were studied. It was found that the carbonyl group at C-11 is more beneficial for aromatase inhibition than the hydroxyl group, and that the C-ring epoxides were more potent than the C-ring olefins, leading to the discovery of a very strong AI, compound 7, with an IC50 of 0.011 mu M, better than Exemestane, the steroidal AI in clinical use, which presents an IC50 of 0.050 mu M. In another approach, we explored the biological activity of A-ring C-1/C-2 steroidal olefins and epoxides in relation to aromatase inhibition and compared it with the biological activity of C-ring C-9/C-11 steroidal olefins and epoxides. On the contrary to what was observed for the C-ring olefins and epoxides, the A-ring epoxides were less potent than A-ring olefins. Finally, the effect of 713 -methyl substitution on aromatase inhibition was compared with 7 alpha-methyl substitution, showing that 713 -methyl is better than 7 alpha-methyl substitution. Molecular modelling studies showed that the 713 -methyl on C-7 seems to protrude into the opening to the access channel of aromatase in comparison to the 7 alpha-methyl. This comparison led to find the best steroidal AI (12a) of this work with IC50 of 0.0058 mu M. Compound 12a showed higher aromatase inhibition capacity than two of the three AIs currently in clinical use.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter? (2020)
Article in International Scientific Journal
Mellado, M; Mella, J; Gonzalez, C; Vina, D; Uriarte, E; Matos, MJ
Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives (2019)
Article in International Scientific Journal
Fais, A; Kumar, A; Medda, R; Pintus, F; Delogu, F; Matos, MJ; Era, B; Delogu, GL
Novel pyridine-2,4,6-tricarbohydrazide derivatives: Design, synthesis, characterization and in vitro biological evaluation as alpha- and beta-glucosidase inhibitors (2014)
Article in International Scientific Journal
Riaz, S; Khan, IU; Yar, M; Ashraf, M; Rehman, TU; Shaukat, A; Jamal, SB; Duarte, VCM; Alves, MJ

See all (18)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-22 at 11:38:38 | Privacy Policy | Personal Data Protection Policy | Whistleblowing